Financial Analyst
IBEX
Financial Analyst
IBEX
Biotech company: antibodies and gene therapy
Will provide in-depth analysis and strategic recommendations to company leadership across several key areas as well as special projects relevant to driving revenue or profitability across the enterprise
Essential Duties and Responsibilities:
•Through robust modeling and analysis, this position will create, track, forecast and analyze financial information to aid the business in making critical, time-sensitive decisions
•Supports monthly, quarterly, and annual reporting process for Executive leadership team, delivering quality and insightful reports and analytics on a timely manner including central and business-wide reporting
•Responsible for executing/implementing enterprise-wide planning processes including annual operating plan, monthly forecast cycle and actuals report outs to senior management
•Analyzes enterprise-wide strategic initiatives with financial modeling and provide recommendations to management for delivering long and short-term business objectives
•Develops presentation materials and analysis for ELT, BOD, and key departmental partners as a decision support partner to the organization
•Manages CapEx reporting and assists with modeling of economic justifications and return on invested capital analysis
•Develops cash flow and regional forecasts including tracking of and justification for addback items
•Produces accurate and timely financial information and analysis; promote an environment of strong internal controls and efficiencies
•Provides value-added analytics and KPI tracking to improve enterprise financial performance
•Carries out responsibilities in accordance with the organization's principles, policies, and applicable law
Job Qualifications
Knowledge of ERP systems (preferably Microsoft Dynamics Business Central) and financial reporting tools
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Explore more opportunities at IBEX